Ameriprise’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.99M | Sell |
173,905
-7,122
| -4% | -$363K | ﹤0.01% | 2002 |
|
|
2025
Q4 | $9M | Sell |
181,027
-2,288
| -1% | -$111K | ﹤0.01% | 1996 |
|
|
2025
Q3 | $8.76M | Buy |
183,315
+10,140
| +6% | +$408K | ﹤0.01% | 2014 |
|
|
2025
Q2 | $5.46M | Sell |
173,175
-279,509
| -62% | -$8.96M | ﹤0.01% | 2289 |
|
|
2025
Q1 | $14.8M | Buy |
452,684
+2,423
| +0.5% | +$85.9K | ﹤0.01% | 1504 |
|
|
2024
Q4 | $16.3M | Sell |
450,261
-95,794
| -18% | -$3.37M | ﹤0.01% | 1474 |
|
|
2024
Q3 | $17M | Sell |
546,055
-18,356
| -3% | -$573K | ﹤0.01% | 1425 |
|
|
2024
Q2 | $15.1M | Sell |
564,411
-1,859
| -0.3% | -$53.9K | ﹤0.01% | 1453 |
|
|
2024
Q1 | $19.3M | Buy |
566,270
+6,568
| +1% | +$196K | 0.01% | 1318 |
|
|
2023
Q4 | $16.2M | Sell |
559,702
-9,317
| -2% | -$247K | ﹤0.01% | 1399 |
|
|
2023
Q3 | $15.7M | Sell |
569,019
-26,206
| -4% | -$798K | 0.01% | 1380 |
|
|
2023
Q2 | $17.9M | Sell |
595,225
-83,614
| -12% | -$2.93M | 0.01% | 1333 |
|
|
2023
Q1 | $24.6M | Sell |
678,839
-19,451
| -3% | -$748K | 0.01% | 1128 |
|
|
2022
Q4 | $24.9M | Sell |
698,290
-95,267
| -12% | -$3.31M | 0.01% | 1087 |
|
|
2022
Q3 | $26.9M | Sell |
793,557
-31,503
| -4% | -$1.03M | 0.01% | 996 |
|
|
2022
Q2 | $23.9M | Sell |
825,060
-22,255
| -3% | -$637K | 0.01% | 1099 |
|
|
2022
Q1 | $27.4M | Buy |
847,315
+21,987
| +3% | +$674K | 0.01% | 1117 |
|
|
2021
Q4 | $24.1M | Sell |
825,328
-14,190
| -2% | -$431K | 0.01% | 1278 |
|
|
2021
Q3 | $22.4M | Buy |
839,518
+36,277
| +5% | +$974K | 0.01% | 1183 |
|
|
2021
Q2 | $24.7M | Buy |
803,241
+38,264
| +5% | +$1.17M | 0.01% | 1198 |
|
|
2021
Q1 | $20M | Buy |
764,977
+9,923
| +1% | +$278K | 0.01% | 1329 |
|
|
2020
Q4 | $19M | Buy |
755,054
+64,316
| +9% | +$1.38M | 0.01% | 1256 |
|
|
2020
Q3 | $14.4M | Buy |
690,738
+52,493
| +8% | +$1.19M | 0.01% | 1291 |
|
|
2020
Q2 | $15.2M | Sell |
638,245
-145,047
| -19% | -$3.2M | 0.01% | 1235 |
|
|
2020
Q1 | $14.1M | Buy |
783,292
+23,283
| +3% | +$489K | 0.01% | 1156 |
|
|
2019
Q4 | $18M | Buy |
760,009
+129,434
| +21% | +$3.14M | 0.01% | 1269 |
|
|
2019
Q3 | $17.3M | Sell |
630,575
-61,383
| -9% | -$1.82M | 0.01% | 1246 |
|
|
2019
Q2 | $22.9M | Buy |
691,958
+248,525
| +56% | +$8.52M | 0.01% | 1064 |
|
|
2019
Q1 | $15.5M | Sell |
443,433
-36,404
| -8% | -$1.35M | 0.01% | 1325 |
|
|
2018
Q4 | $15.9M | Buy |
479,837
+21,463
| +5% | +$923K | 0.01% | 1209 |
|
|
2018
Q3 | $23.1M | Sell |
458,374
-90,891
| -17% | -$4.49M | 0.01% | 1190 |
|
|
2018
Q2 | $32.9M | Sell |
549,265
-40,170
| -7% | -$2.08M | 0.01% | 870 |
|
|
2018
Q1 | $27M | Sell |
589,435
-11,119
| -2% | -$464K | 0.01% | 960 |
|
|
2017
Q4 | $23.9M | Sell |
600,554
-81,238
| -12% | -$3.21M | 0.01% | 957 |
|
|
2017
Q3 | $27.3M | Buy |
681,792
+102,341
| +18% | +$4.43M | 0.01% | 864 |
|
|
2017
Q2 | $25M | Sell |
579,451
-34,968
| -6% | -$1.24M | 0.01% | 877 |
|
|
2017
Q1 | $19.2M | Sell |
614,419
-283,962
| -32% | -$7.61M | 0.01% | 1044 |
|
|
2016
Q4 | $22.7M | Buy |
898,381
+9,316
| +1% | +$208K | 0.01% | 917 |
|
|
2016
Q3 | $22M | Sell |
889,065
-23,675
| -3% | -$536K | 0.01% | 881 |
|
|
2016
Q2 | $18.6M | Buy |
912,740
+134,544
| +17% | +$2.39M | 0.01% | 950 |
|
|
2016
Q1 | $11.9M | Buy |
778,196
+34,755
| +5% | +$453K | 0.01% | 1288 |
|
|
2015
Q4 | $9.99M | Sell |
743,441
-74,041
| -9% | -$1.15M | 0.01% | 1445 |
|
|
2015
Q3 | $11.5M | Sell |
817,482
-445,542
| -35% | -$8.28M | 0.01% | 1353 |
|
|
2015
Q2 | $21.4M | Sell |
1,263,024
-164,973
| -12% | -$2.35M | 0.01% | 966 |
|
|
2015
Q1 | $17.3M | Sell |
1,427,997
-38,712
| -3% | -$366K | 0.01% | 1095 |
|
|
2014
Q4 | $12.2M | Sell |
1,466,709
-3,388
| -0.2% | -$28.5K | 0.01% | 1342 |
|
|
2014
Q3 | $12.8M | Sell |
1,470,097
-262,484
| -15% | -$2.37M | 0.01% | 1269 |
|
|
2014
Q2 | $19M | Sell |
1,732,581
-124,770
| -7% | -$1.11M | 0.01% | 1061 |
|
|
2014
Q1 | $16.6M | Sell |
1,857,351
-122,726
| -6% | -$1.13M | 0.01% | 1134 |
|
|
2013
Q4 | $14.9M | Buy |
1,980,077
+1,182,725
| +148% | +$8.27M | 0.01% | 1203 |
|
|
2013
Q3 | $5.85M | Sell |
797,352
-94,770
| -11% | -$637K | ﹤0.01% | 1837 |
|
|
2013
Q2 | $5.74M | Buy |
+892,122
| New | +$5.25M | ﹤0.01% | 1803 |
|
Other funds holding SUPN
VPM
VCM
NAMI
AC
Ameriprise's SUPN Position: Q1 2026 in Review
Ameriprise reduced its Supernus Pharmaceuticals (SUPN) stake by 3.9% in Q1 2026, selling an estimated $363K and leaving 173,905 shares worth $8.99M. The position accounts for ﹤0.01% of the portfolio, ranked #2002.
Ameriprise first reported a position in SUPN in Q2 2013 and has held it in 52 quarters since. The position peaked at $32.9M in Q2 2018. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.
- Ameriprise held 173,905 shares of Supernus Pharmaceuticals worth $8.99M as of Q1 2026.
- Ameriprise sold 7,122 Supernus Pharmaceuticals shares in Q1 2026, an estimated $363K.
- Supernus Pharmaceuticals made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2002 holding.
- Ameriprise first reported a position in Supernus Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Supernus Pharmaceuticals position peaked at $32.9M in Q2 2018.
- 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.